Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Prostatic Neoplasms × Metoclopramide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Vomiting 5 Nausea 4 Neoplasms 3 Lymphoma 2 Solid Tumors 1 Prostatic Neoplasms 1 Polyps 1 Mouth Neoplasms 1 Metastatic Neuroendocrine Prostate Cancer 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Acute 1 Intestinal Obstruction 1 Hypopharyngeal Neoplasms 1 Critical Illness 1 Colonic Neoplasms 1 Breast Neoplasms 1

Interventions

Docetaxel 263 Prednisone 207 enzalutamide 167 Leuprolide 162 Radiotherapy 153 Abiraterone Acetate 145 Magnetic Resonance Spectroscopy 139 bicalutamide 115 Goserelin 115 Androgen Antagonists 103 Radiosurgery 98 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 96 apalutamide 81 Specimen Handling 68 gallium 68 PSMA-11 67 abiraterone 66 darolutamide 56 Surveys and Questionnaires 53 Gonadotropin-Releasing Hormone 53 Biopsy 53 Radiation 51 Brachytherapy 50 cabazitaxel 47 Triptorelin Pamoate 47 Standard of Care 44 pembrolizumab 43 Zoledronic Acid 43 luprolide acetate gel depot 42 Radiotherapy, Intensity-Modulated 41 Carboplatin 41

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02441894 2017-01-24

PEGAZUS

Sanofi

Phase 4 Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡